Advertisement

Ads Placeholder
Loading...

Bavarian Nordic A/S

BVNRYPNK
Healthcare
Biotechnology
$10.18
$-0.07(-0.68%)
U.S. Market opens in 3h 43m

Bavarian Nordic A/S (BVNRY) Stock Overview

Explore Bavarian Nordic A/S’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap2.4B
P/E Ratio11.04
EPS (TTM)$0.91
ROE0.11%
Fundamental Analysis

AI Price Forecasts

1 Month$9.73
3 Months$10.69
1 Year Target$11.16

BVNRY Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Bavarian Nordic A/S (BVNRY) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 57.90, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $11.16.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 11.04 and a market capitalization of 2.4B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-1.02%
5-Day Change
2.47%
1-Month Change
8.04%
3-Month Change
-1.60%
6-Month Change
-14.82%
Year-to-Date (YTD) Change
2.17%
1-Year Change
45.34%
3-Year Change
8.04%
5-Year Change
-35.95%
All-Time (Max) Change
71.66%

Contact Information

45 33 26 83 83
Philip Heymans Alle 3, Hellerup, NaN, 2900

Company Facts

16,450 Employees
IPO DateApr 3, 2013
CountryDK
Actively Trading

Frequently Asked Questions